COVID-19: Zydus Cadila seeks emergency approval of its needleless vaccine

This needleless vaccine, in case it gets approval, will be the world’s first plasmid deoxyribonucleic acid vaccine against COVID-19 …

COVID-19: Expert committee approves Covaxin for children aged 2-18 years

No data on clinical trials of Bharat Biotech vaccine on children available publicly yet

Covid-19 no longer public health emergency. But a new mRNA vaccine has been authorised for emergency use

The Phase III clinical trial was conducted with 3,140 participants who were randomisd to receive either GEMCOVAC-OM or Covidshield in 20 centres …

Regulate online sale of drugs in India, say experts

Indian Medical Association warns that data generated from online visits and sale could be sold to other websites or hospitals

Drug pricing body puts cap on trade margin for 42 anti-cancer drugs

Experts say move will not benefit patients as drug prices are already too high and the cap only negligible

COVID-19: Why ICMR okayed hydroxychloroquine as preventive med

Hydroxychloroquine has been found to be effective against SARS-CoV-2 in laboratory studies

DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered

CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections

Don’t doubt India’s drug regulator on COVID-19 vaccines: Government

Weekly press meeting also releases details of COVID-19 vaccination; healthcare and frontline workers, seniors to be immunised on priority basis

Make unethical drug trials a punishable offence, say experts

Current laws do not fix penalty if such practices are found

Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred

Both manufacturers have been asked for more data before a final decision can be reached  

Victims of vaccination

Vaccine trials in a Madhya Pradesh government hospital are making children sick. Culprit: harmful chemicals in high amounts

Parliament committee indicts drugs regulatory authority

Drugs which are banned in developed countries are approved in India without clinical trials

COVID-19: Centre doesn’t clarify basis for CDSCO authorising remdesivir

Government also does not provide clarity about whether remdesivir should be given to only severe patients

‘Policies will infuse objectivity in health research’

Several health and research policies in the country are either in draft stage or just recommendatory in nature. This hampers regulation of …

Substantiate allegations against Ranbaxy, says Supreme Court

Experts say allegations against the generic pharma company motivated by vested interests

Indian rotavirus vaccine found effective during clinical trial

Rotovac costs fifty times less than brands sold by global pharma companies

India bans animal testing for cosmetics

Standards for alternative tests to be set; amendments to acts and laws required

New swine flu kit makes disease detection easier in India

Portable testing kit gives results within an hour

Health ministry forms committee to investigate charges by parliamentary standing committee

It will also suggest ways to improve grant of statutory approvals for drugs and functioning of the CDSCO